A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia

Clinical trial NCT00231621 · TERMINATED

Trial details

NCT number: NCT00231621
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Hyperlipidemia Hypertriglyceridemia

Start date: 2001-05-01
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.